×

Enrollment in MS imaging study reaches halfway mark

Enrollment is half complete in an ongoing clinical study at Massachusetts General Hospital (MGH) testing whether a PET imaging tracer can reliably measure myelin damage in people with multiple sclerosis (MS). The Phase 1 study (NCT04699747) is recruiting about 60 people — healthy adults and MS…

Immunology Time..The Target in MS

Tweet Many years ago the new target for MS was reported and it was called RASGRP2. People then wanted to inhibit responses to this protein to treat MS…I thought the idea was a crock and I said this to one of the leading authors of…